Darius Kharabi is CHIEF BUSINESS OFFICER of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 59,728 shares of KALA, which is worth approximately $369,119. The most recent transaction as insider was on Jun 26, 2024, when has been sold 5,158 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $24,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.7K
0% 3M change
3.51% 12M change
Total Value Held $369,119

Darius Kharabi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 26 2024
SELL
Open market or private sale
$24,500 $4.75 p/Share
5,158 Reduced 7.95%
59,728 Common Stock
May 31 2024
SELL
Open market or private sale
$1,406 $6.09 p/Share
231 Reduced 0.35%
64,886 Common Stock
Jan 04 2024
SELL
Open market or private sale
$9,321 $6.73 p/Share
1,385 Reduced 2.08%
65,117 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
4,600 Added 6.47%
66,502 Common Stock
Jun 22 2023
BUY
Grant, award, or other acquisition
-
36,847 Added 37.31%
61,902 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
2,648 Added 9.56%
25,055 Common Stock
Mar 10 2023
BUY
Grant, award, or other acquisition
-
6,977 Added 23.74%
22,407 Common Stock
Jan 04 2023
BUY
Grant, award, or other acquisition
-
9,525 Added 38.15%
15,439 Common Stock
Feb 15 2022
SELL
Other acquisition or disposition
-
9 Reduced 0.06%
15,430 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
295,657 Added 50.0%
295,657 Common Stock
DK

Darius Kharabi

CHIEF BUSINESS OFFICER
Watertown, MA

Track Institutional and Insider Activities on KALA

Follow Kala Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALA shares.

Notify only if

Insider Trading

Get notified when an Kala Pharmaceuticals, Inc. insider buys or sells KALA shares.

Notify only if

News

Receive news related to Kala Pharmaceuticals, Inc.

Track Activities on KALA